Log in or Sign up for Free to view tailored content for your specialty!
Gastrointestinal Cancer News
Society leaders: 2017 likely to be time of ‘unprecedented’ advances in hematology, oncology
This calendar year could be a pivotal one for oncology and hematology research, drug approvals and clinical trial results.
Tecentriq–Avastin regimen extends PFS in PD-L1–positive advanced renal cell carcinoma
The combination of atezolizumab and bevacizumab conferred no significant PFS benefit compared with sunitinib monotherapy among patients with locally advanced or metastatic renal cell carcinoma, according to an intention-to-treat analysis of a phase 2 study presented at Genitourinary Cancers Symposium.
Log in or Sign up for Free to view tailored content for your specialty!
Sorafenib benefit dependent on hepatitis status in patients with HCC
Sorafenib improved OS among patients with hepatocellular carcinoma who were hepatitis C positive but hepatitis B negative, suggesting that the beneficial effects of sorafenib may be based on hepatitis status, according to results of a meta-analysis.
Tivantinib fails to improve OS in hepatocellular carcinoma
A phase 3 study of tivantinib as second-line treatment for hepatocellular carcinoma failed to meet its primary endpoint of improved OS, according to the drug’s manufacturers.
Long-term weight gain linked to esophageal, gastric cancers
Individuals who become overweight in their twenties and progress to obesity later in life may have a threefold increased risk for developing esophageal and gastric cardia adenocarcinomas compared with those who maintain a healthy weight, according to new research published in the British Journal of Cancer.
NYU Langone names liver tumor program director
Theodore H. Welling, III, MD, has been named director of a new liver tumor program at NYU Langone’s Perlmutter Cancer Center.
FDA: More adolescents with cancer should be included in adult trials
Enrollment of adolescents in oncology trials remains significantly lower than that of children.
Use of metaphors may improve participation in clinical trials
The use of metaphors for explaining randomization could ease the difficulty in recruiting patients to participate in randomized clinical trials, according to a study published in the Journal of the National Cancer Institute.
‘Explosive growth’ of interventional oncology prompts formation of new society
The board of directors for World Conference on Interventional Oncology, a nonprofit association that supports and promotes the field, has established a society to further its mission.
Eight updates in cancer prevention
National Cancer Prevention Month, established by a U.S. Senate resolution and observed every February since 2004, is intended to draw attention to the fact that approximately 70% of malignancies may be prevented through diet or other lifestyle changes.
-
Headline News
Cooking, stove use among potential household health hazards for women
October 03, 20244 min read -
Headline News
FDA approves Cologuard Plus, Exact Sciences’ next generation stool test for CRC screening
October 04, 20241 min read -
Headline News
BLOG: Selling your practice when you own the real estate
October 04, 20243 min read
-
Headline News
Cooking, stove use among potential household health hazards for women
October 03, 20244 min read -
Headline News
FDA approves Cologuard Plus, Exact Sciences’ next generation stool test for CRC screening
October 04, 20241 min read -
Headline News
BLOG: Selling your practice when you own the real estate
October 04, 20243 min read